doi: 10.3748/wjg.v28.i23.2546 Summary Keywords diabetic kidney disease, gut microbiota, short-chain fatty acids (SCFAs), probiotics, fecal microbiota transplantation (FMT) Citation Wang X, Liu X, Gong F, Jiang Y, Zhang C, Zhou W and Zhang W (2025) Targeting gut microbiota for diabetic nephropathy treatment: probiotics, dietary interventions, and fecal microbiota transplantation
Side effects such as nausea, vomiting or constipation may occur when restarting a GLP-1, so it's important to pay attention
138 The interaction between CST1 and GPX4 improves the stability of GPX4 protein and reduces the intracellular ROS, thus inhibiting ferroptosis
The right choice depends on the patients needs and how they react to treatment